Systemic sclerosis (scleroderma) trials in Argentina
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleRollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment
- Where
- Quilmes, San Miguel
- Age
- 5 years to 80 years
- People
- 1,072 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07691970 - Phase 3Taking peopleA Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- Where
- CABA, Maipu, Quilmes, Rosario
- Age
- 18 years and over
- People
- 448 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07497087 · EU 2025-523884-39-00 - Phase 3Taking peopleA Study to Investigate the Long-term Safety and Efficacy of Belimumab in Adults With Interstitial Lung Disease (ILD) Associated With Systemic Sclerosis (SSc) and Other Connective Tissue Diseases (CTD) (BLISSconneCTD-OLE)
- Where
- Buenos Aires, Ciudad Autonoma Buenos Aires, Ciudad Autonoma de Buenos Aire, Santa Fe
- Age
- 18 years and over
- People
- 514 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06716606 - Phase 2/3Taking peopleA Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- Where
- Buenos Aires, Ciudad Autonoma Buenos Aires, Ciudad Autonoma de Buenos Aire
- Age
- 18 years and over
- People
- 300 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT05878717 · EU 2023-503219-14-01 - No phaseTaking peopleRegistry of Autoimmune Interstitial Lung Disease
- Where
- Buenos Aires
- Age
- 18 years and over
- People
- 1,000
- Run by
- EPIMAR registry
See details and how to joinNCT05365009